AEYE Comprehensive Screening (AEYE-CS)
AEYE Comprehensive Screening
AI-based diagnostic screening for a broad range of diseases using retinal images
CAUTION: Federal (US) law restricts this device to investigational use only.
NOT SOLD IN THE US
AEYE Comprehensive Screening utilizes AI technology to diagnose or predict the development of a broad range of diseases from retinal images. Current diseases diagnosed and/or predicted include diabetic retinopathy, glaucoma, AMD, diabetes, cataract, diabetic macular edema, cardiovascular disease, occlusion, and hypertension; and the list continues to grow.
​
The accuracy of disease detection or prediction is backed by studies on large data sets, and supported by rigorous statistical analyses.
The first practical point-of-care diagnostic screening for a wide range of diseases
How it works
Image
A single image per eye is obtained using an indicated camera
Analyze
Images are analyzed by the AI
Result
Diagnoses are produced in under a minute
Benefits of Point-of-Care Comprehensive Screening
.png)
Practical
The first solution to require only 1 image per eye; rarely requires dilation
Real-time diagnosis
Diagnosis in under a minute
